Silver nitroprusside nanoparticles for breast cancer therapy: in vitro and in vivo approach
Nanoscale · 2023
DOI: 10.1039/d3nr00221g ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2023. Verfasst von Swapnali Londhe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad - 500007, Telangana State, India. crpatra…. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Metal Nanoparticles. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
AgNNPs have significant tumor regression ability and can be used for efficient breast cancer therapeutics in the upcoming future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad - 500007, Telangana State, India. crpatra@iict.res.in.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, U.P., India.
- Analytical Division, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad - 500007, Telangana State, India.
Förderung
- Council of Scientific and Industrial Research, India
Zitieren
APA
Londhe, S., Haque, S., Tripathy, S., Bojja, S., & Patra, C. R. (2023). Silver nitroprusside nanoparticles for breast cancer therapy: in vitro and in vivo approach. Nanoscale. https://doi.org/10.1039/d3nr00221g
Vancouver
Londhe S, Haque S, Tripathy S, Bojja S, Patra CR. Silver nitroprusside nanoparticles for breast cancer therapy: in vitro and in vivo approach. Nanoscale. 2023. doi:10.1039/d3nr00221g
BibTeX
@article{Londhe2023,
author = {Londhe, Swapnali and Haque, Shagufta and Tripathy, Sanchita and Bojja, Sreedhar and Patra, Chitta Ranjan},
title = {Silver nitroprusside nanoparticles for breast cancer therapy: in vitro and in vivo approach},
journal = {Nanoscale},
year = {2023},
doi = {10.1039/d3nr00221g}
}
EUVIMED